Compounds > ilmofosine
Page last updated: 2024-08-23

ilmofosine and Benign Neoplasms

ilmofosine has been researched along with Benign Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Derry, C; Giantonio, BJ; McAleer, C; McPhillips, JJ; O'Dwyer, PJ1
Giantonio, BJ; McAleer, C; McPhillips, J; O'Dwyer, PJ; Schilder, R; von Mehren, M1
Berges, W; Ebeling, K; Hottenrott, G; Mechl, Z; Schlimok, G; Scholten, T; Sterz, R; Strohmeyer, G; Westerhausen, M; Winkelmann, M1

Trials

3 trial(s) available for ilmofosine and Benign Neoplasms

ArticleYear
Phase I and pharmacokinetic study of the cytotoxic ether lipid ilmofosine administered by weekly two-hour infusion in patients with advanced solid tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Feb-15, Volume: 10, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Kinetics; Lipids; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Phospholipid Ethers; Time Factors

2004
Phase I trial of ilmofosine as a 24 hour infusion weekly.
    Investigational new drugs, 1995, Volume: 13, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Phospholipid Ethers; Treatment Outcome

1995
Treatment results of the thioether lipid ilmofosine in patients with malignant tumours.
    Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Drug Evaluation; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Neoplasms; Pancreatic Neoplasms; Phospholipid Ethers

1992